SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973379-24-000124
Filing Date
2024-03-15
Accepted
2024-03-15 06:33:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3769
  Complete submission text file 0001973379-24-000124.txt   5313
Mailing Address 55TH-56TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124
Business Address 55TH-56TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124 862160578000
I-Mab (Subject) CIK: 0001778016 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39173 | Film No.: 24752421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 55TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124
Business Address
Feng Gigi Qi (Reporting) CIK: 0001979025 (see all company filings)

Type: 144